Table 2. Outcome of PNH patients... | American Society of Hematology

Table 2.

Outcome of PNH patients undergoing nonmyeloablative hematopoietic cell transplantation

		No. of cells transfused per kg*
Patient no.	Donor HLA match	CD34, × 10⁶/kg	CD3, × 10⁶/kg	ANC nadir, × 10³ cells per μL	Acute GVHD grade/system	Chronic GVHD	Day GPI-negative granulocytes disappeared (<0.03%)†	Status	Survival after transplantation, days
1	6 of 6	21.1	4.3	0.007	No	Yes/limited	86	Alive	1325+
								CR
2	6 of 6	7.1	3.3	0.003	No	Yes/limited	118	Alive	672+
								CR
3	6 of 6	4.9	2.5	0.003	III/GI	Yes/limited	39	Alive	356+
								CR
4	6 of 6	8.0	3.7	0.002	IV/GI	No	25	Alive	315+
								CR
5	6 of 6	13.4	2.6	0.002	No	No	85	Alive	268+
								CR

		No. of cells transfused per kg*
Patient no.	Donor HLA match	CD34, × 10⁶/kg	CD3, × 10⁶/kg	ANC nadir, × 10³ cells per μL	Acute GVHD grade/system	Chronic GVHD	Day GPI-negative granulocytes disappeared (<0.03%)†	Status	Survival after transplantation, days
1	6 of 6	21.1	4.3	0.007	No	Yes/limited	86	Alive	1325+
								CR
2	6 of 6	7.1	3.3	0.003	No	Yes/limited	118	Alive	672+
								CR
3	6 of 6	4.9	2.5	0.003	III/GI	Yes/limited	39	Alive	356+
								CR
4	6 of 6	8.0	3.7	0.002	IV/GI	No	25	Alive	315+
								CR
5	6 of 6	13.4	2.6	0.002	No	No	85	Alive	268+
								CR

HLA indicates human leukocyte antigen; ANC, absolute neutrophil count; GVHD, graft-versus-host disease; GI, gastrointestinal.

The number of cells per kilogram of recipient body weight that were transfused.

The percent of GPI-anchored protein-negative granulocytes on last assessment following transplantation.